These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2114988

  • 1. Abnormal 3,4-dihydroxyphenylalanine (dopa) concentrations in plasma and urine of patients with cystic fibrosis.
    Schöni MH, Türler K, Käser H, Kraemer R.
    Eur J Clin Invest; 1990 Jun; 20(3):272-8. PubMed ID: 2114988
    [Abstract] [Full Text] [Related]

  • 2. [Determination of free and conjugated catecholamines, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid in the urine and blood plasma by high pressure liquid chromatography].
    Kogan BM, Drozdov AZ, Man'kovskaia IV, Filatova TS.
    Klin Lab Diagn; 1995 Jun; (3):25-8. PubMed ID: 8689050
    [Abstract] [Full Text] [Related]

  • 3. Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma.
    Alvarado CS, Faraj BA, Kim TH, Camp VM, Bain RP, Ragab AH.
    Am J Pediatr Hematol Oncol; 1985 Jun; 7(3):221-7. PubMed ID: 3934994
    [Abstract] [Full Text] [Related]

  • 4. A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine.
    Brown MJ, Dollery CT.
    Br J Clin Pharmacol; 1981 Jan; 11(1):79-83. PubMed ID: 6783056
    [Abstract] [Full Text] [Related]

  • 5. Dopamine-beta-hydroxylase in patients with cystic fibrosis.
    Schöni MH, Türler K, Käser H, Kraemer R.
    Eur J Pediatr; 1986 Apr; 145(1-2):80-3. PubMed ID: 3732334
    [Abstract] [Full Text] [Related]

  • 6. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
    Eldrup E, Mogensen P, Jacobsen J, Pakkenberg H, Christensen NJ.
    Acta Neurol Scand; 1995 Aug; 92(2):116-21. PubMed ID: 7484057
    [Abstract] [Full Text] [Related]

  • 7. [Simultaneous fluorimetric determination of noradrenaline, adrenaline, dopamine and dopa (3,4- dihydroxyphenylalanine) in the urine].
    Valori C, Brunori CA, Renzini V, Porcellati C.
    Ann Ist Super Sanita; 1971 Aug; 7(2):414-21. PubMed ID: 5155304
    [No Abstract] [Full Text] [Related]

  • 8. Simultaneous measurement of urinary and plasma norepinephrine, epinephrine, dopamine, dihydroxyphenylalanine, and dihydroxyphenylacetic acid by coupled-column high-performance liquid chromatography on C8 and C18 stationary phases.
    Benedict CR.
    J Chromatogr; 1987 Jan 09; 385():369-75. PubMed ID: 3104375
    [Abstract] [Full Text] [Related]

  • 9. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
    Kuchel O, Buu NT, Edwards DJ.
    J Lab Clin Med; 1990 Apr 09; 115(4):449-53. PubMed ID: 1969915
    [Abstract] [Full Text] [Related]

  • 10. Plasma catecholamines in the chronically cannulated sheep fetus: predominance of L-dihydroxyphenylalanine.
    Ben-Jonathan N, Arbogast LA, Rhoades TA, Schillo KK, Pau KY, Jackson GL.
    Endocrinology; 1983 Jul 09; 113(1):216-21. PubMed ID: 6407822
    [Abstract] [Full Text] [Related]

  • 11. Plasma and urinary catecholamines in patients with cystic fibrosis.
    Schöni MH, Türler K, Käser H, Kraemer R.
    Pediatr Res; 1985 Jan 09; 19(1):47-52. PubMed ID: 3969312
    [Abstract] [Full Text] [Related]

  • 12. Dihydroxyphenylalanine secretion in a malignant pheochromocytoma.
    Anton AH, Greer M, Sayre DF, Williams CM.
    Am J Med; 1967 Mar 09; 42(3):469-75. PubMed ID: 6018863
    [No Abstract] [Full Text] [Related]

  • 13. Secretion of dopa in phaeochromocytoma.
    Louis WJ, Doyle AE, Heath WC, Robinson MJ.
    Br Med J; 1972 Nov 11; 4(5836):325-7. PubMed ID: 4637512
    [Abstract] [Full Text] [Related]

  • 14. Differential catecholamine responses to protein intake in healthy and hypertensive subjects.
    Kuchel O.
    Am J Physiol; 1998 Oct 11; 275(4):R1164-73. PubMed ID: 9756547
    [Abstract] [Full Text] [Related]

  • 15. [On the determination of adrenaline, noradrenaline, dopamine and dopa in a single urine sample].
    Matlina ESh, Kiseleva ZM.
    Probl Endokrinol Gormonoter; 1966 Oct 11; 12(2):111-6. PubMed ID: 6004103
    [No Abstract] [Full Text] [Related]

  • 16. Derivation of urinary dopamine from plasma dopa.
    Zimlichman R, Levinson PD, Kelly G, Stull R, Keiser HR, Goldstein DS.
    Clin Sci (Lond); 1988 Nov 11; 75(5):515-20. PubMed ID: 3151165
    [Abstract] [Full Text] [Related]

  • 17. [Various features of dopamine metabolism in schizophrenia].
    Anokhina IP, Kogan BM.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981 Nov 11; 81(9):1343-7. PubMed ID: 6798791
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
    Eldrup E, Clausen N, Scherling B, Schmiegelow K.
    Scand J Clin Lab Invest; 2001 Nov 11; 61(6):479-90. PubMed ID: 11681538
    [Abstract] [Full Text] [Related]

  • 19. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
    Kvetnanský R, Goldstein DS, Weise VK, Holmes C, Szemeredi K, Bagdy G, Kopin IJ.
    J Neurochem; 1992 Jun 11; 58(6):2296-302. PubMed ID: 1573408
    [Abstract] [Full Text] [Related]

  • 20. Reactivity of the dopa-dopamine-noradrenaline-adrenaline system in epileptic patients.
    Karlov VA, Gleiser MA.
    Neurosci Behav Physiol; 1986 Jun 11; 16(1):49-53. PubMed ID: 3090474
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.